162 related articles for article (PubMed ID: 8033815)
1. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum.
Schneyer AL; Rzucidlo DA; Sluss PM; Crowley WF
Endocrinology; 1994 Aug; 135(2):667-74. PubMed ID: 8033815
[TBL] [Abstract][Full Text] [Related]
2. Alpha 2-macroglobulin is a binding protein of inhibin and activin.
Vaughan JM; Vale WW
Endocrinology; 1993 May; 132(5):2038-50. PubMed ID: 7682939
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids.
Krummen LA; Woodruff TK; DeGuzman G; Cox ET; Baly DL; Mann E; Garg S; Wong WL; Cossum P; Mather JP
Endocrinology; 1993 Jan; 132(1):431-43. PubMed ID: 7678220
[TBL] [Abstract][Full Text] [Related]
4. Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically.
Schneyer AL; Hall HA; Lambert-Messerlian G; Wang QF; Sluss P; Crowley WF
Endocrinology; 1996 Jan; 137(1):240-7. PubMed ID: 8536619
[TBL] [Abstract][Full Text] [Related]
5. Activin-binding proteins in human serum and follicular fluid.
Schneyer AL; O'Neil DA; Crowley WF
J Clin Endocrinol Metab; 1992 Jun; 74(6):1320-4. PubMed ID: 1592877
[TBL] [Abstract][Full Text] [Related]
6. A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state.
McConnell DS; Wang Q; Sluss PM; Bolf N; Khoury RH; Schneyer AL; Midgley AR; Reame NE; Crowley WF; Padmanabhan V
J Clin Endocrinol Metab; 1998 Mar; 83(3):851-8. PubMed ID: 9506739
[TBL] [Abstract][Full Text] [Related]
7. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
8. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
9. Regulation of follistatin production by rat granulosa cells in vitro.
Shintani Y; Dyson M; Drummond AE; Findlay JK
Endocrinology; 1997 Jun; 138(6):2544-51. PubMed ID: 9165047
[TBL] [Abstract][Full Text] [Related]
10. Activin-A regulates follistatin secretion from cultured rat anterior pituitary cells.
Bilezikjian LM; Corrigan AZ; Vaughan JM; Vale WM
Endocrinology; 1993 Dec; 133(6):2554-60. PubMed ID: 8243277
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human follistatin structure: identification of two discontinuous N-terminal sequences coding for activin A binding and structural consequences of activin binding to native proteins.
Wang Q; Keutmann HT; Schneyer AL; Sluss PM
Endocrinology; 2000 Sep; 141(9):3183-93. PubMed ID: 10965889
[TBL] [Abstract][Full Text] [Related]
12. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
Sidis Y; Tortoriello DV; Holmes WE; Pan Y; Keutmann HT; Schneyer AL
Endocrinology; 2002 May; 143(5):1613-24. PubMed ID: 11956142
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. I. Serum profile of rh-inhibin A and rh-activin A in the immature female rat.
Woodruff TK; Krummen LA; Chen S; DeGuzman G; Lyon R; Baly DL; Allison DE; Garg S; Wong WL; Hebert N
Endocrinology; 1993 Feb; 132(2):715-24. PubMed ID: 8425490
[TBL] [Abstract][Full Text] [Related]
14. Follistatin binds to both activin and inhibin through the common subunit.
Shimonaka M; Inouye S; Shimasaki S; Ling N
Endocrinology; 1991 Jun; 128(6):3313-5. PubMed ID: 2036994
[TBL] [Abstract][Full Text] [Related]
15. Follistatin and its role as an activin-binding protein.
Sugino H; Sugino K; Hashimoto O; Shoji H; Nakamura T
J Med Invest; 1997 Aug; 44(1-2):1-14. PubMed ID: 9395712
[TBL] [Abstract][Full Text] [Related]
16. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
[TBL] [Abstract][Full Text] [Related]
17. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations.
Schneyer AL; Fujiwara T; Fox J; Welt CK; Adams J; Messerlian GM; Taylor AE
J Clin Endocrinol Metab; 2000 Sep; 85(9):3319-30. PubMed ID: 10999828
[TBL] [Abstract][Full Text] [Related]
18. Identification of naturally occurring follistatin complexes in human biological fluids.
Wang EY; Draper LB; Lee E; Polak A; Sluss P; Weiss J; Woodruff TK
Biol Reprod; 1999 Jan; 60(1):8-13. PubMed ID: 9858480
[TBL] [Abstract][Full Text] [Related]
19. Unique recognition of activin and inhibin by polyclonal antibodies to inhibin subunits.
Funaba M; Murata T; Fujimura H; Murata E; Abe M; Takahashi M; Torii K
J Biochem; 1996 May; 119(5):953-60. PubMed ID: 8797097
[TBL] [Abstract][Full Text] [Related]
20. Partial characterization of inhibin, activin, and follistatin in the term human placenta.
de Kretser DM; Foulds LM; Hancock M; Robertson DM
J Clin Endocrinol Metab; 1994 Aug; 79(2):502-7. PubMed ID: 8045969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
